China Passes Law Granting Doctors the Right to use Off-Label Drugs

China Passes Law Granting Doctors the Right to use Off-Label Drugs

A new law in China grants physicians explicit rights to prescribe or try out off-label drugs in a bid to bring greater opportunity to drug makers in the world’s most populous nation and second-largest economy. Starting March 1, 2022, physicians may use off-label drugs that can benefit both patients and pharmaceutical companies. Patients will have new options to potentially treat any number of conditions, while drug makers could benefit from the expanded use of their drugs. While American physicians have long had the right to prescribe off-label drugs during the pandemic, government health agencies, regulators, and medical licensing societies have put increasing pressure on physicians to not prescribe ivermectin, for example, pointing to a centralization of control over local physicians.

Recently, China’s Pharma DJ reported on the new law based on the Chinese Pharmacological Society definition of an off-label drug as in the “use of drugs for an unapproved indication or in an unapproved dosage, treatment course, route of administration and patient group.” In reality, the State in China is merely codifying what physicians have long done anyway, writes Minhua Chu. Th...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee